
Every successful Life Sciences consulting business is built on a simple truth: great proposals teams don’t just respond — they shape growth.
As VCLS continues to scale globally across Biotech, MedTech, and HealthTech, we are investing deliberately in the future of our proposals function — strengthening today’s execution while building the systems, tools, and capabilities that will define tomorrow.
This role exists because we believe excellence in proposals is a competitive advantage — and because the future of this work will be smarter, more automated, and more human, not less.
Why This Role Matters
This is not a transactional role. And it’s not “just automation.” As such experience with Regulatory Proposals is essential.
You will sit at the intersection of sales, science and delivery helping ensure that:
You will work closely with an experienced Life Sciences Proposals Director known for authentic, supportive leadership.
If you understand that a great proposal is both craft and a tool of persuasion, this role was designed with you in mind.
What You’ll Do
Proposal Delivery & Quality
Library, Automation & AI Enablement
Cross-Functional Collaboration
Requirements
Who You Are
You take pride in getting the details right — and you see structure as a strength, not a constraint.
You understand that proposals are:
You likely bring:

From discovery to product launch and lifecycle management
At VCLS (Voisin Consulting Life Sciences), regulatory science guides Biotechnology, Pharmaceutical and Medtech manufacturers throughout product development and commercialization. Starting early in the process, from discovery to the patient, VCLS assists innovators in designing optimized product development plans and regulatory strategies, combining the health ecosystem with commercial success. With a presence in seven locations across three continents and over 200 employees, VCLS serves a broad range of healthtech developers and their investors.
Together, we accompany global stakeholders to expedite HealthTech products from discovery to patient access and beyond by bridging Science to Regulatory and Market Access strategies.